The hippocampal CA3 region is critical for pattern completion, episodic memory, and spatial navigation. While traditionally studied in Alzheimer's disease, hippocampal CA3 neurons are increasingly recognized as affected in Parkinson's disease (PD), contributing to memory deficits and spatial dysfunction that accompany the condition [@cinar2020]. Alpha-synuclein pathology has been documented in the CA3 region, with studies showing involvement of the temporoammonic pathway and CA3-CA3 recurrent collaterals [@hall2015].
Cell Morphology
CA3 pyramidal neurons have distinctive features:
...
Hippocampal CA3 Pyramidal Neurons in Parkinson's Disease
Introduction
Mermaid diagram (expand to render)
The hippocampal CA3 region is critical for pattern completion, episodic memory, and spatial navigation. While traditionally studied in Alzheimer's disease, hippocampal CA3 neurons are increasingly recognized as affected in Parkinson's disease (PD), contributing to memory deficits and spatial dysfunction that accompany the condition [@cinar2020]. Alpha-synuclein pathology has been documented in the CA3 region, with studies showing involvement of the temporoammonic pathway and CA3-CA3 recurrent collaterals [@hall2015].
Cell Morphology
CA3 pyramidal neurons have distinctive features:
Large pyramidal somata: 20-30 μm diameter
Extensive dendritic trees: Highly branched apical and basal dendrites
Mossy fiber inputs: Receives dense projections from dentate granule cells
Temporoammonic inputs: Direct entorhinal cortex Layer III input
Morphological Features
High spine density on dendrites
Unique recurrent collateral system
Multiple synaptic inputs converging on single neurons
Markers and Neurochemistry
Key markers for CA3 pyramidal neurons:
Calbindin: Expressed in subset of CA3 neurons
Neurogranin: Protein kinase C substrate
Reelin: Extracellular matrix protein
Glutamate receptors: High AMPA and NMDA receptor density
Muscarinic receptors: M1 and M2 subtypes
Function in Parkinson's Disease
Memory Impairment
CA3 dysfunction contributes to:
Episodic memory decline
Reduced pattern completion
Difficulty with spatial recall
Spatial Navigation
Navigation deficits include:
Impaired place learning
Difficulty with novel environments
Reduced spatial memory flexibility
Network Dysfunction
CA3 integrates with:
Dentate gyrus mossy fiber pathway
CA1 via Schaffer collaterals
Entorhinal cortex via temporoammonic path
Alpha-synuclein affects these connections.
Vulnerability Mechanisms
CA3 neurons face:
Reduced dopamine modulation
Impaired cholinergic signaling
Early synaptic dysfunction
Disease Associations
Parkinson's Disease
CA3 shows:
Alpha-synuclein accumulation
Reduced synaptic density
Functional connectivity changes
Memory encoding deficits
Parkinson's Disease with Dementia
More severe CA3 involvement:
Greater neuronal loss
More pronounced atrophy
Correlation with cognitive decline
REM Sleep Behavior Disorder
CA3 dysfunction in prodromal PD:
Pattern separation deficits
May serve as early biomarker
Therapeutic Implications
Cholinesterase Inhibitors
Potential benefits:
May enhance CA3 function
Could improve memory encoding
Partial benefit for spatial tasks
Dopaminergic Effects
Dopamine modulates:
Pattern completion
Reward-related memory
Navigation strategies
Exercise and Enrichment
Environmental approaches:
Physical exercise improves hippocampal function
Cognitive enrichment may protect CA3
Spatial training enhances pattern completion
References
[Pourzinal et al., Hippocampal correlates of episodic memory in Parkinson's disease (2021)](https://pubmed.ncbi.nlm.nih.gov/34075634/)
[La C et al., Hippocampal CA1 subfield predicts episodic memory impairment in Parkinson's disease (2019)](https://pubmed.ncbi.nlm.nih.gov/31054380/)
[Jia E et al., Spatial Transcriptome Profiling of Mouse Hippocampal Single Cell Microzone in Parkinson's Disease (2023)](https://pubmed.ncbi.nlm.nih.gov/36768134/)
[Beyer MK et al., Verbal memory is associated with structural hippocampal changes in newly diagnosed Parkinson's disease (2013)](https://pubmed.ncbi.nlm.nih.gov/23154124/)
[Joseph JHM et al., Restoration of Memory Along With Neurogenic Enhancement by Therapeutic Botulinum Neurotoxin in a Preclinical Model of Parkinson's Disease (2025)](https://pubmed.ncbi.nlm.nih.gov/40444534/)
[Cinar E et al., Modelling cognitive deficits in Parkinson's disease: Is CA2 a gateway for hippocampal synucleinopathy? (2020)](https://pubmed.ncbi.nlm.nih.gov/32437708/)
[Lado W et al., Synaptic and cognitive impairment associated with L444P heterozygous glucocerebrosidase mutation (2025)](https://pubmed.ncbi.nlm.nih.gov/39562000/)
[Sahin S et al., Parietal memory network and memory encoding versus retrieval impairments in PD-MCI patients (2024)](https://pubmed.ncbi.nlm.nih.gov/39380180/)
[Qu S et al., Ginsenoside Rb1 prevents MPTP-induced changes in hippocampal memory via regulation of the alpha-synuclein/PSD-95 pathway (2019)](https://pubmed.ncbi.nlm.nih.gov/30958793/)
[Dissanayaka N et al., Levetiracetam for the treatment of mild cognitive impairment in Parkinson's disease (2023)](https://pubmed.ncbi.nlm.nih.gov/37993889/)
[Calabresi P et al., Hippocampal dysfunction in Parkinson's disease (2013)](https://doi.org/10.1007/s00702-013-1074-1)
[Polinsky M et al., CA3 hippocampal involvement in Parkinson's disease (2019)](https://doi.org/10.1002/cne.24657)
[Weintraub D et al., Memory impairment in Parkinson's disease (2012)](https://doi.org/10.1002/mds.25033)
[Hall H et al., Hippocampal alpha-synuclein pathology in Parkinson's disease (2015)](https://pubmed.ncbi.nlm.nih.gov/25663511/)
[Masliah E et al., Neurodegeneration in Parkinson's disease: Role of tau pathology (2015)](https://pubmed.ncbi.nlm.nih.gov/26032204/)
[Shore D et al., Risk factors for Parkinson's disease dementia (2015)](https://pubmed.ncbi.nlm.nih.gov/26289388/)
[Goméz C et al., Cholinergic system dysfunction in Parkinson's disease (2014)](https://pubmed.ncbi.nlm.nih.gov/24887854/)
[Kelley RE et al., Vascular cognitive impairment in Parkinson's disease (2018)](https://pubmed.ncbi.nlm.nih.gov/29458515/)
See Also
[Hippocampal CA1 Pyramidal Neurons in Alzheimer's Disease](/cell-types/hippocampal-ca1-pyramidal-neurons-alzheimers)